Institut National de la Santé Et de la Recherche Médicale, France clinical trial pipeline

6 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 3 with minor changes only.

1. Notable

   CAVB · Molecular Characterization for Understanding Biliary Atresia

   Primary completion pushed from Aug 7, 2026 to Feb 6, 2031

   Also in this update: Enrollment closed, study ongoing; Study completion moved earlier from Feb 7, 2032 to Feb 7, 2031

   Institut National de la Santé Et de la Recherche Médicale, France·Not applicable· NCT04272515· Registry history of NCT04272515 on ClinicalTrials.gov (opens the registry)

   Oct 22, 2026

2. Notable

   CARE 13-11 · Child Cognitive-Affective Resilience Following…CARE 13-11 · Child Cognitive-Affective Resilience Following 13-11 Event : A Pluridisciplinary Study of Intergenerational Transmission of a Traumatic Event

   Primary and study completion pushed from Jan 15, 2027 to Sep 30, 2028

   Institut National de la Santé Et de la Recherche Médicale, France·Not applicable· NCT07203443· Registry history of NCT07203443 on ClinicalTrials.gov (opens the registry)

   Oct 19, 2026

3. Notable

   EpiMicro · Multi-level Approach of Brain Activity Using…EpiMicro · Multi-level Approach of Brain Activity Using Intracranial Electrodes in Epileptic Patients

   Enrollment increased: 50 → 80 participants

   Institut National de la Santé Et de la Recherche Médicale, France·Not applicable· NCT04653012· Registry history of NCT04653012 on ClinicalTrials.gov (opens the registry)

   Sep 28, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.